Journal of Pharmaceutical and Biomedical Analysis

Journal of Pharmaceutical and Biomedical Analysis

  • Volume 15
  • Issue 15
  • ISSN 0731-7085
  • SCImago Journal Rank (SJR): 0.777
  • Source Normalized Impact per Paper (SNIP): 1.246
  • Impact Factor: 3.935
  • Five Year Impact Factor: 3.563

Subscription options

No personal options available.
Next planned ship date: Dec 21, 2021


This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focusing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome.

Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradants.

Papers dealing with the analytical aspects of traditional folk medicines are acceptable if the results are expected to attract the interest of readers also outside the area of origin, i.e. they have a focus on innovative analytical approaches. Regional differences in the phytochemical content of traditional folk medicine will not be considered. Manuscripts reporting on the analysis of novel phytochemicals will only be considered if their biological activity has been previously published in an international medium. Pharmacokinetic studies of traditional folk medicine will only be considered if only the identified components have been demonstrated to be solely responsible for the pharmacological activity.

Bioanalytical papers (pharmacokinetic, bioequivalence, protein and DNA binding studies) are accepted if the focus is on innovative analytical methodology. Manuscripts describing the pharmacokinetic profile of a single compound will not be considered for review. Pharmacokinetic studies will only be considered if they offer new profiles of a drug(s) and its metabolite(s) or new understandings of the mechanisms in drug disposition or response of existing drugs. Analytical studies on new investigational drugs that are currently in the preclinical phase are only acceptable if their pharmacological activity is well documented in an international medium.

Human subjects research must provide ethical approval and should include the name of the approving committee and the name of the institution and reference number where approval was granted. Animal studies must be approved from their Institutions Animal Care and Use Committee or any equivalent ethics committee accompanied by the reference number. For blood sampling procedures in rodents, retro-orbital bleeding will only be considered if a minimum of 7 days is allowed between repeat sampling. Furthermore, in the evaluation of the manuscript the editors reserve the right to determine whether the animal experimental technique is appropriate.

In determining the suitability of submitted articles for publication, particular scrutiny will be placed on the degree of novelty and significance of the research and the extent to which it adds to existing knowledge in pharmaceutical and biomedical analysis. In all submissions to the journal, authors must address the question of how their proposed methodology compares with previously reported methods. A substantial body of work cannot be fractionated into different shorter papers.

Product details

  • SCImago Journal Rank (SJR): 0.777
  • Source Normalized Impact per Paper (SNIP): 1.246
  • Impact Factor: 3.935
  • Five Year Impact Factor: 3.563
  • ISSN: 0731-7085
  • Issues: 15
  • Volume: 15
Editorial board

Author services

Prepare your article for submission

Celebrate your publication

Additional services

Publication schedule

Issue volumeIssue yearPlanned ship dateActual ship date
192C2021Nov 19, 2020Dec 29, 2020
193C2021Dec 15, 2020Dec 29, 2020
194C2021Jan 20, 2021Feb 17, 2021
195C2021Feb 11, 2021Feb 17, 2021
196C2021Mar 08, 2021Mar 02, 2021
197C2021Mar 24, 2021Mar 22, 2021
198C2021Apr 19, 2021Apr 15, 2021
199C2021May 11, 2021May 10, 2021
200C2021May 26, 2021May 24, 2021
201C2021Jun 11, 2021Jun 11, 2021
202C2021Jun 24, 2021Jun 21, 2021
203C2021Aug 03, 2021Jul 29, 2021
204C2021Sep 01, 2021Aug 31, 2021
205C2021Oct 05, 2021Oct 07, 2021
206C2021Oct 26, 2021Oct 21, 2021
207C2022Nov 24, 2021Nov 19, 2021
208C2022Dec 21, 2021
209C2022Jan 20, 2022
210C2022Feb 11, 2022
211C2022Mar 08, 2022
212C2022Mar 24, 2022
213C2022Apr 19, 2022
214C2022May 10, 2022
215C2022May 26, 2022
216C2022Jun 13, 2022
217C2022Jun 24, 2022
218C2022Aug 09, 2022
219C2022Sep 01, 2022
220C2022Oct 05, 2022
221C2022Oct 26, 2022
222C2023Nov 22, 2022
223C2023Dec 13, 2022